- Acquired by SEQENS, Dec 2021
- Went public, Nov 2017
- Acquired Vanamali Organics, Feb 2021
About
Wavelength Pharmaceuticals develops and manufactures active pharmaceutical ingredients and select finished dosage forms. The company focuses on differentiated products that require sophisticated manufacturing processes. Its solution provides customers with comprehensive technical support and in-depth regulatory support across the entire product lifecycle, from project inception to commercial production. Wavelength Pharmaceuticals core strengths include complex chemistry, innovative process development, crystalline forms, and particle design. It tailors customized solutions to meet individual customer requirements, including full spectrum API CDMO services from preclinical grams to multi-ton commercial quantities.
Funding history · 1 round · — total
Q&A
- What is Wavelength Pharmaceuticals' primary business?
- Wavelength Pharmaceuticals develops and manufactures active pharmaceutical ingredients (APIs) and select finished dosage forms, focusing on differentiated products requiring sophisticated manufacturing processes.
- When was Wavelength Pharmaceuticals founded?
- Wavelength Pharmaceuticals was founded in January 1987.
- What is the current employee count for Wavelength Pharmaceuticals?
- Wavelength Pharmaceuticals has 51-200 employees.
- When was Wavelength Pharmaceuticals acquired and by whom?
- Wavelength Pharmaceuticals was acquired by SEQENS in December 2021.
- What was a significant financial event for Wavelength Pharmaceuticals in 2017?
- In November 2017, Wavelength Pharmaceuticals was acquired by SK Capital Partners for $110,000,000.
- What was the most recent funding round for Wavelength Pharmaceuticals?
- The most recent funding round for Wavelength Pharmaceuticals was a grant in July 2022.
- Does Wavelength Pharmaceuticals hold any patents?
- Yes, Wavelength Pharmaceuticals holds one patent.
- Where are Wavelength Pharmaceuticals' offices located?
- Wavelength Pharmaceuticals has offices in Ramat Hovav and Petah Tikva, Israel; Barcelona, Spain; and Wayne, USA.
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | wavelengthpharma.com |
|---|---|
| linkedin.com/company/35473024 | |
| facebook.com/wavelengthpharma | |
| YouTube | youtube.com/@wavelengthpharma5837 |
Identifiers & details
| Former names | Chemagis, Perrigo API, Perrigo |
|---|---|
| Founded | 1987-1 |
| Employees (exact) | 95 |
| Offices | Barcelona; Wayne; Petah Tikva |
| Status reason | Acquired by SK Capital Partners on Nov, 2017 |
Acquisitions & public offerings
Acquired by SEQENS 2021-12
| Acquired | Date | Amount |
|---|---|---|
| Vanamali Organics | 2021-02 |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2021-12 | ||||
| 2017-11 | $110.0M |
Radar intelligence
Web history (Wayback)
| Domain | wavelengthpharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|